跳至主要内容
临床试验/NCT03074773
NCT03074773已完成1 期

Paravertebral Block in Coarctation of the Aorta

Cairo University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年10月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Intraoperative fentanyl needs

研究概览

简要总结

Anesthetic management for surgery of aortic coarctation needs special care due to severe pain during lateral thoracotomy incision, the intraoperative hemodynamic instability related to skin incision at lateral thoracotomy, clamping and declamping of the aorta, needs of large doses of analgesia perioperative, needs of vasodilators. Also, postoperative care of the patients after repair is very important issue. The investigators will compare the effect of para-vertebral block with bupivacaine alone or with dexamethasone on Intra and postoperative analgesia.

详细描述

The patients will be divided randomly by sealed envelope into 2 equal groups. Group I (n=30) will receive paravertebral block with 0.5mg/kg bupivacaine 0.25% diluted with isotonic saline (total volume 15ml) and group II (n=30) will receive paravertebral block with 0.5mg/kg 0.25% bupivacaine and 0.1mg/kg dexamethasone.intraoperative fentanyl needs, Intra and postoperative hemodynamics and OPS pain scores will be recorded. Possible risks as hypertension will be treated by nitroglycerin infusion 0.5ug/kg/min or tachycardia (HR more than 20% than baseline) will be managed by additional doses of fentanyl 1-2ug/kg, bradycardia (20% decrease from the baseline) will be managed by atropine 0.02mg/kg. Also, the complications of paravertebral block as peridural and intravascular injection can be avoided by careful aspiration before injection and injection while visualization of the needle by U/S.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
4 Months 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 4m-6 years males and females scheduled for surgery for coarctation of the aorta

排除标准

  • patients with associated other cardiac anomalies (e.g. VSD), patients with airway abnormality, patients with heart failure, patients with endocrine disorders, patients with history of convulsions, neurological disorder, hepatic, renal and neuromuscular diseases, coagulopathy, history of hyperthermia, infection at site of the block and family history of hypersensitivity

研究组 & 干预措施

paravertebral block with bupivacaine

Active Comparator

this group will receive 0.5mg/kg bupivacaine 0.25% diluted with isotonic saline (total volume 15ml) paravertebral block ultrasound guided pre-emptively

干预措施: ultrasound (Device)

paravertebral block with bupivacaine

Active Comparator

this group will receive 0.5mg/kg bupivacaine 0.25% diluted with isotonic saline (total volume 15ml) paravertebral block ultrasound guided pre-emptively

干预措施: paravertebral block (Procedure)

paravertebral block with bupivacaine

Active Comparator

this group will receive 0.5mg/kg bupivacaine 0.25% diluted with isotonic saline (total volume 15ml) paravertebral block ultrasound guided pre-emptively

干预措施: Bupivacaine (Drug)

paravertebral block with bupivacaine

Active Comparator

this group will receive 0.5mg/kg bupivacaine 0.25% diluted with isotonic saline (total volume 15ml) paravertebral block ultrasound guided pre-emptively

干预措施: isotonic saline (Other)

paravertebral block with bupivacaine and dexamethasone

Active Comparator

this group will receive 0.5mg/kg bupivacaine 0.25% mixed to 0.1 mg/kg dexamethasone diluted with isotonic saline (total volume 15ml) paravertebral block ultrasound guided pre-emptively

干预措施: Dexamethasone (Drug)

paravertebral block with bupivacaine and dexamethasone

Active Comparator

this group will receive 0.5mg/kg bupivacaine 0.25% mixed to 0.1 mg/kg dexamethasone diluted with isotonic saline (total volume 15ml) paravertebral block ultrasound guided pre-emptively

干预措施: ultrasound (Device)

paravertebral block with bupivacaine and dexamethasone

Active Comparator

this group will receive 0.5mg/kg bupivacaine 0.25% mixed to 0.1 mg/kg dexamethasone diluted with isotonic saline (total volume 15ml) paravertebral block ultrasound guided pre-emptively

干预措施: paravertebral block (Procedure)

paravertebral block with bupivacaine and dexamethasone

Active Comparator

this group will receive 0.5mg/kg bupivacaine 0.25% mixed to 0.1 mg/kg dexamethasone diluted with isotonic saline (total volume 15ml) paravertebral block ultrasound guided pre-emptively

干预措施: Bupivacaine (Drug)

结局指标

主要结局

Intraoperative fentanyl needs

时间窗: 3hours

total fentanyl consumption intraoperatively

postoperative analgesic requirements

时间窗: 24hours

total narcotic consumption

次要结局

  • the first time the analgesic required(24 hours)
  • extubation time(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amany Hassan Saleh

Lecture of anethesia, Cairo university

Cairo University

研究点 (1)

Loading locations...

相似试验